JENNIFER DINSMOORE: Open Payments
NPI 1023592516 · CARO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 56 payments from 15 companies in 2025. Trend: 2023 $892 · 2024 $1,043 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $304 |
| Otsuka America Pharmaceutical, Inc. | 6 | $140 |
| Amgen Inc. | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| PFIZER INC. | 3 | $79 |
| Exact Sciences Corporation | 3 | $70 |
| SCPHARMACEUTICALS INC. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
Products named: REXULTI, SKYRIZI, RINVOQ, COSENTYX, TRELEGY ELLIPTA, ELIQUIS, TAVNEOS, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
